CompanyNYMOX PHARMACEUTICAL CORP
USHealth CareSIC 2835
Identifiers| Type | Value |
|---|
| cik | 0001018735 |
| ticker | NYMX |
Recent transactions| Date | Type | Insider | Qty | Price | Signals |
|---|
| 02 May 2022 | PURCHASE | Robinson James George | 1,151,515 | 1.65 USD | |
| 02 May 2022 | PURCHASE | Robinson James George | 1,151,515 | 0.00 USD | deriv |
| 22 Apr 2021 | PURCHASE | Robinson James George | 51 | 2.08 USD | |
| 22 Apr 2021 | PURCHASE | Robinson James George | 800 | 2.10 USD | |
| 22 Apr 2021 | PURCHASE | Robinson James George | 4,949 | 2.09 USD | |
| 22 Apr 2021 | PURCHASE | Robinson James George | 5,000 | 2.05 USD | |
| 22 Apr 2021 | PURCHASE | Robinson James George | 3,100 | 2.11 USD | |
| 22 Apr 2021 | PURCHASE | Robinson James George | 1,900 | 2.13 USD | |
| 22 Apr 2021 | PURCHASE | Robinson James George | 7,000 | 2.07 USD | |
| 21 Apr 2021 | PURCHASE | Robinson James George | 900 | 2.08 USD | |
| 21 Apr 2021 | PURCHASE | Robinson James George | 4,100 | 2.08 USD | |
| 21 Apr 2021 | PURCHASE | Robinson James George | 6,000 | 2.08 USD | |
| 21 Apr 2021 | PURCHASE | Robinson James George | 2,000 | 2.09 USD | |
| 22 Apr 2021 | PURCHASE | Robinson James George | 200 | 2.09 USD | |
| 22 Apr 2021 | PURCHASE | Robinson James George | 2,900 | 2.09 USD | |
| 22 Apr 2021 | PURCHASE | Robinson James George | 1,100 | 2.09 USD | |
| 10 Jul 2019 | PURCHASE | Robinson James George | 100 | 1.72 USD | |
| 10 Jul 2019 | PURCHASE | Robinson James George | 166 | 1.73 USD | |
| 10 Jul 2019 | PURCHASE | Robinson James George | 600 | 1.72 USD | |
| 10 Jul 2019 | PURCHASE | Robinson James George | 300 | 1.73 USD | |
| 10 Jul 2019 | PURCHASE | Robinson James George | 5,834 | 1.73 USD | |
| 09 Jul 2019 | PURCHASE | Robinson James George | 7,000 | 1.63 USD | |
| 05 Jul 2019 | PURCHASE | Robinson James George | 9,000 | 1.45 USD | |
| 03 Jul 2019 | PURCHASE | Robinson James George | 8,000 | 1.54 USD | |
| 01 Jul 2019 | PURCHASE | Robinson James George | 295 | 1.37 USD | |
NYMOX PHARMACEUTICAL CORP — Insider transactions, executives, recent activity | InsiderLens